In order to bring you the latest cancer-related health care policy and news, we at NCCS combined our ACA Updates and What Caught Our Eye (WCOE) content into a weekly email and blog post. We aim to make this a concise, one-stop summary of what you need to know as we continue working together to make cancer care better for everyone.
Your feedback is always welcome to make our content more useful to you. Please send comments to email@example.com.
HEALTH CARE HIGHLIGHT
NCCS and 30+ Patient Orgs Raise Concerns Over Senate Pre-Ex Bill
This week, NCCS and more than 30 other patient advocacy organizations submitted a letter to Senator Tillis (R-NC) detailing why his bill does not go far enough in protecting pre-existing conditions despite his intentions. The bill title, “Ensuring Coverage for Patients with Pre-Existing Conditions Act” (S.3388), is misleading and, if passed, would not provide adequate coverage for those covered under current law with pre-existing conditions.
The reason is that while the bill requires insurers to provide health care plans to people regardless of health, it does not require the insurers to cover the costs of the care for the pre-existing condition itself.
NCCS and others stated in the letter:
The bill is seen by many as an attempt to calm fears related to the Texas lawsuit challenging the constitutionality of the ACA. If that lawsuit is eventually successful, it would wipe out the pre-existing condition protections millions of Americans have come to rely on.
CHART OF THE WEEK
The ACA’s Pre-Existing Condition Protections Remain Popular with the Public, including Republicans, As Legal Challenge Looms This Week
Kaiser Family Foundation
As there are several pending lawsuits that aim to either attack or protect the ACA, we thought it was important to share this chart again by KFF that shows how important pre-existing condition protections are for the vast majority of Americans.
Via Center on Budget and Policy Priorities
On October 2, federal rules take effect that will fundamentally change how short-term health plans are administered. This article serves as another reminder of why these changes are so concerning, namely:
Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies
Via STAT News
This report provides compelling evidence that clinical trials continue to have meaningful racial disparities. It specifically looks at a clinical trial for a new drug for multiple myeloma, where one out of five people diagnosed in the US are African-American. In the trial however, only 1.8 percent of participants were African-American.
Via Wall Street Journal
This article highlights the increasing use of “cancer coaches” to help guide patients through a cancer experience. While it is helpful that patients have somewhere to turn for additional assistance, it raises serious ethical concerns that only patients with financial means can afford this level of care.
Via The Bloodline With LLS (Podcast)
An informative interview with Kate Houghton, of Critical Mass, about the “Deferment for Active Cancer Treatment Act” (H.R. 2976). This bill “calls for federal student loan borrowers to be eligible for deferment while they are receiving treatment for cancer.”